新诊断ANCA相关性血管炎前心血管疾病风险增加:一项丹麦全国性研究
该研究基于丹麦全国登记数据(1996-2021年),采用巢式病例对照设计,将2371例肉芽肿性多血管炎和显微镜下多血管炎患者与7113例对照按1:3匹配。结果显示,诊断前12个月内AAV患者任何心血管结局患病率为10.3%(对照3.8%,HR 3.05),MACE为2.4%(对照1.3%,HR 1.98),且风险随诊断临近而升高,诊断前1个月任何心血管结局HR达10.73。作者结论认为AAV与诊断前数月心血管疾病风险增加相关,强调早期临床警惕心血管疾病的重要性。
要点
- AAV诊断前12个月内任何心血管结局患病率为10.3%,显著高于对照的3.8%(HR 3.05)。
- 诊断前1个月任何心血管结局HR为10.73,MACE的HR为5.78,风险随诊断临近而升高。
- 除室性心律失常/ICD植入/心脏骤停外,其余各项心血管结局发生率均显著升高。
核心结论
- AAV疾病与诊断前数月心血管疾病风险增加相关,作者强调早期临床警惕心血管疾病的重要性。
研究设计与样本
- 采用巢式病例对照框架,通过丹麦全国登记系统识别1996年至2021年间的肉芽肿性多血管炎和显微镜下多血管炎患者,并按1:3与无AAV的年龄和性别匹配对照进行匹配,每个对照被赋予与其对应病例相同的索引日期(AAV诊断日期)。
- 使用条件 logistic 回归计算索引日期前12个月、6个月、3个月、2个月和1个月内MACE、缺血性心脏病、冠状动脉造影、心力衰竭、静脉血栓栓塞、心房颤动、缺血性卒中、心包炎以及室性心律失常/植入式心律转复除颤器植入/心脏骤停(VA/ICD/CA)的调整风险比(HR)。
- 共纳入2371例AAV患者(中位年龄63岁,53.7%为男性),与7113例对照匹配。
主要发现
- 索引日期前12个月内,AAV患者任何心血管结局患病率为10.3%,对照为3.8%,HR 3.05(95% CI 2.48-3.75);MACE患病率为2.4%,对照为1.3%,HR 1.98(95% CI 1.39-2.82)。
- 心血管结局风险随诊断临近而类似升高,索引日期前1个月HR最高:任何心血管结局HR 10.73(95% CI 7.05-16.32),MACE HR 5.78(95% CI 2.67-12.52)。
- 在单项分析中,除VA/ICD/CA外,所有结局均观察到显著更高的发生率。
临床怎么用
- 作者结论指出,AAV疾病与诊断前数月心血管疾病风险增加相关,强调了对心血管疾病早期临床警惕的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether patients with ANCA-associated vasculitis (AAV) have an increased risk of cardiovascular disease in the months prior to diagnosis of AAV. METHODS: Using a nested case-control framework, patients with granulomatosis with polyangiitis and microscopic polyangiitis were identified through the Danish Nationwide Registries from 1996 to 2021 and matched 1:3 with age- and sex-matched controls without AAV. Each control was assigned the same index date (date of AAV diagnosis) as their corresponding case. Conditional logistic regression was used to compute adjusted hazard ratios (HRs) for major adverse cardiovascular events (MACE), ischaemic heart disease, coronary angiogram, heart failure, venous thromboembolism, atrial fibrillation, ischaemic stroke, pericarditis and ventricular arrhythmias/implantable cardioverter defibrillator implantation/cardiac arrest (VA/ICD/CA) within 12 months, 6 months, 3 months, 2 months and 1 month before index date. RESULTS: A total of 2371 patients with AAV (median age 63 years, 53.7% male) were matched with 7113 controls. The prevalence of any cardiovascular outcome and MACE within 12 months preceding index date were 10.3% and 2.4% for AAV, compared with 3.8% [HR 3.05 (95% CI 2.48-3.75)] and 1.3% [HR 1.98 (95% CI 1.39-2.82)] of controls. The risk of cardiovascular outcomes was similarly increased in temporal proximity to the diagnosis, with the highest HR at 1 month prior to index date: any cardiovascular outcome [HR 10.73 (95% CI 7.05-16.32)] and MACE [HR 5.78 (95% CI 2.67-12.52)]. In individual analysis, a significantly higher rate was observed for all outcomes (excluding VA/ICD/CA). CONCLUSIONS: AAV disease is associated with an increased risk of cardiovascular disease in the months preceding diagnosis, which underlines the importance of early clinical vigilance towards cardiovascular disease.
引用
- Nygaard L, Polcwiartek C, Nelveg-Kristensen KE, et al. Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study. Rheumatology (Oxford). 2024. PMID: 37481712. doi:10.1093/rheumatology/kead377
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。